All Fields
Computer Science
Medicine
FAQ
Contact
Sign in
pagibaximab
Â
Topic mentions per year
Topic mentions per year
2009-2015
0
1
2
3
2009
2015
Related topics
Related topics
1 relation
Broader (1)
Monoclonal Antibodies
Related mentions per year
Related mentions per year
1948-2018
1940
1960
1980
2000
2020
pagibaximab
Monoclonal Antibodies
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Anti-lipoteichoic acid monoclonal antibody (pagibaximab) studies for the prevention of staphylococcal bloodstream infections in preterm infants.
Manisha Patel
,
David A. S. Kaufman
Expert opinion on biological therapy
2015
INTRODUCTION Advances in modern medicine have given very low birth weight (VLBW) infants a better chance of survival; however…Â
(More)
Is this relevant?
2011
2011
A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis.
L. Weisman
,
Helen Thackray
,
+14 authors
James J. Mond
Pediatrics
2011
BACKGROUND Pagibaximab, a human chimeric monoclonal antibody developed against lipoteichoic acid, was effective against…Â
(More)
Is this relevant?
Review
2011
Review
2011
Antibody-based therapeutics to watch in 2011.
Janice M. Reichert
mAbs
2011
This overview of 25 monoclonal antibody (mAb) and 5 Fc fusion protein therapeutics provides brief descriptions of the candidates…Â
(More)
Is this relevant?
Review
2011
Review
2011
Recent advances in prevention of sepsis in the premature neonates in NICU.
Paolo Manzoni
,
Stefano Rizzollo
,
+7 authors
D. Farina
Early human development
2011
Sepsis-related morbidity and mortality are major problems in NICU. Preterm neonates display clinical characteristics that make…Â
(More)
Is this relevant?
2009
2009
Phase 1/2 double-blind, placebo-controlled, dose escalation, safety, and pharmacokinetic study of pagibaximab (BSYX-A110), an antistaphylococcal monoclonal antibody for the prevention of…
L. Weisman
,
Helen Thackray
,
+7 authors
G. Fischer
Antimicrobial agents and chemotherapy
2009
Staphylococcal sepsis is a major cause of morbidity and mortality in very-low-birth-weight (VLBW) infants. A human chimeric…Â
(More)
Is this relevant?
2009
2009
Safety and pharmacokinetics of a chimerized anti-lipoteichoic acid monoclonal antibody in healthy adults.
L. Weisman
,
G. Fischer
,
+7 authors
James J. Mond
International immunopharmacology
2009
A chimerized (murine/human) monoclonal antibody (pagibaximab) against lipoteichoic acid (LTA) and protective in animal models for…Â
(More)
Is this relevant?